Biopsy

A prostate biopsy, also known as a core needle biopsy or a transrectal ultrasound (TRUS), is used to determine if any suspicious looking tissues are cancerous or not. A biopsy is conducted when an abnormal lump is found during a digital rectal exam (DRE) or if the prostate-specific antigen (PSA) blood test reveals high levels of PSA.

Prostate Cancer Canada graciously acknowledges the Princess Margaret Cancer Centre for sharing this video with us.
 
How is a biopsy performed?
  • You will be given a local anesthetic. 
  • A biopsy needle and ultrasound probe is then inserted into your rectum. Your doctor will use the ultrasound as a visual aid to help him/her guide the needle through your rectum. The needle quickly pierces through the rectal wall, enters the prostate and removes a tissue sample.
  • 8-12 samples will be taken depending on the area to be examined.
  • Procedure lasts between 15 and 20 minutes. 
What can I expect after the procedure?
 
Everyone responds differently to procedures. Following a prostate biopsy, it is common to experience the following:
  • Bleeding from your rectum or penis
  • Blood in the stool, urine or semen
  • Pain
These common symptoms may persist for 2 weeks or more. If you have concerns about these symptoms, discuss them with your doctor.


 

For more information and support:


Help us take the first steps toward prevention. Donate Now




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.
More

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body.
More

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More


Click here for news archive